It's time for Indian generic companies to rethink their strategies, says Bhupesh Bhandari. In July, the European Commission imposed fines of euro 427.7 million on Servier of France and five......
The European Commission on Wednesday imposed a fine of Euro146 million on nine pharma companies, including Ranbaxy Laboratories, for delaying market entry of cheaper generic versions of......
European regulators will clamp down on "pay-for-delay" deals in the pharmaceutical sector this month, fining Denmark's Lundbeck, India's Ranbaxy and seven other generic drug manufacturers for......
Patent settlements between pharmaceutical companies that make original drugs and their generic manufacturing rivals are to come under renewed scrutiny from the European Union's competition......
Sun Pharmaceutical Industries and its subsidiary, Caraco Pharmaceutical Laboratories, have reached a settlement agreement with drugmaker Forest Laboratories and licensing partner H Lundbeck AS,......